Position
Numerai GP LLC in Amneal Pharmaceuticals, Inc.
Back to the book · All holders of AMRX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$14K$12.60 → $12.43
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 124.9K | $1.57M | — | — | — | 0.2% |
| Q1 2026 | 82.3K | $1.02M | $12.43 | −$14K | −$536.9K | 0.1% |